Jun 17, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
FDA Approves Tarceva As A Maintenance Therapy For Advanced Non-Small Cell Lung Cancer
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2140129" data-attributes="member: 124445"><p>OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that the U.S. Food and Drug Administration (FDA) approved the daily pill Tarceva® (erlotinib) as a maintenance treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. "We are delighted that lung cancer patients and their physicians will have the option of beginning Tarceva therapy in the first-line maintenance setting...<a href="http://feedads.g.doubleclick.net/~a/uWgnDqespi8ExG6TDPBLX8Et608/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/uWgnDqespi8ExG6TDPBLX8Et608/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/uWgnDqespi8ExG6TDPBLX8Et608/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/uWgnDqespi8ExG6TDPBLX8Et608/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/cXZzNqJvaEE" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/cXZzNqJvaEE/3Brp" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2140129, member: 124445"] OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that the U.S. Food and Drug Administration (FDA) approved the daily pill Tarceva® (erlotinib) as a maintenance treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. "We are delighted that lung cancer patients and their physicians will have the option of beginning Tarceva therapy in the first-line maintenance setting...[URL="http://feedads.g.doubleclick.net/~a/uWgnDqespi8ExG6TDPBLX8Et608/0/da"][IMG]http://feedads.g.doubleclick.net/~a/uWgnDqespi8ExG6TDPBLX8Et608/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/uWgnDqespi8ExG6TDPBLX8Et608/1/da"][IMG]http://feedads.g.doubleclick.net/~a/uWgnDqespi8ExG6TDPBLX8Et608/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/cXZzNqJvaEE[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/cXZzNqJvaEE/3Brp]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top